Koios Beverage Corp. (CSE: KBEV; OTC: SNOVF) (the “Company” or “Koios”), is pleased to announce the creation of Cannavated Beverage Co. (“Cannavated”), a wholly-owned subsidiary that will be among the first companies to produce cannabis-infused beverages.
Koios brings its proven experience in the functional beverage industry to the growing cannabis sector. Cannavated drinks will have all of the nootropic health benefits of the winning Koios drink formula, and will target medical cannabis users, who have long called for more choice in the market.
“The industry has proven it is going in the direction of cannabis-infused drinks,” said Chris Miller, CEO of Koios. “It’s healthier. Nobody wants to smoke anymore. The market for beverages is vast, especially when you consider the aging population and the demand for medical cannabis among seniors.”
Cannavated’s longer-term plans include partnering with licensed producers, cultivators and other regulated cannabis companies who want to sell their own line of cannabis drinks. By entering into a “white labelling” turn-key agreement, companies will be able to sell Cannavated drinks under their own brand names and labels.
“We have used hemp oil in our previous product line due it’s cognitive benefits and perfect balance of omega’s,” added Miller. “Using our existing knowledge and experience in the beverage space not only allows us to help licensed producers, but to also reach a wider audience of health-conscious consumers. We are especially excited about the possibility of combining CBDs with our proprietary nootropic blend to create a cannabis-based cognitive beverage.”
The introduction of Cannavated enables Koios to target a whole new demographic, increasing its market reach with a broader and expanding base of consumers. Market demand is expected to grow beyond medical users once the Canadian government legalizes cannabis for recreational use, likely to happen later this year.
The functional beverage market is quickly becoming the go-to drink-of-choice among a new generation of consumers who want low-calorie, nutrient-dense options. Koios will supply its proprietary nootropic recipes to Cannavated, ensuring the cannabis drinks have all of the nutrients and flavour that consumers have come to associate with the brand.
About the Company’s Business
The Company, through its wholly-owned subsidiary Koios, Inc., is an emerging functional beverage company which has an available distribution network of more than 2,000 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Together these distributors represent more than 80,000 bricks and mortar locations across the United States – from sports nutrition stores to large natural grocery chains including Whole Foods and Sunflower markets. Through its partnership with Wishing-U-Well, Koios also enjoys a large presence online, including being an Amazon choice product.
Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products can enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain.
Koios is one of the only drinks in the world to infuse its products with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website: https://www.mentaltitan.com/
On behalf of the Board of Directors of the Company.
KOIOS BEVERAGE CORP.
Chris Miller, CEO and Director
This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements with respect to the statement that the Company’s subsidiary will produce cannabis-infused beverages; the statement that the Company will enter into agreements with licensed producers, cultivators and other regulated cannabis companies to produce cannabis-infused beverages; the statement that the market for cannabis-infused beverages is vast and growing; the statement that the legalization of the recreational use of cannabis in Canada is expected to occur later in 2018; and the statement that Cannavated will allow Koios to target a whole new demographic and increase the Company’s market reach. The forward-looking statements reflect management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements including: (i) adverse market conditions; (ii) changes to the growth and size of the functional beverage market and the cannabis-infused beverage market; (iii) consumer acceptance and adoption of functional beverages and cannabis-infused beverages as compared to other beverages; (iv) changes to the proposed timeline of the Canadian federal government to pass legislation legalizing the adult recreational use of cannabis; (v) that the Company will not be able to enter into an agreement with a licensed producer, cultivator or other regulated cannabis company for the production of cannabis-infused beverages; (vi) changes to the regulations that apply to the Company and licensed producers, cultivators or other regulated cannabis companies or (vii) regulatory changes which may impact the functional beverage and cannabis-infused beverage market. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, levels of activity or performance. Further, any forward-looking statement speaks only as of the date on which such statement is made and, except as required by applicable law, the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for management to predict all of such factors and to assess in advance the impact of such factors on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement. Readers should consult all of the information set forth herein and should also refer to the risk factor disclosure outlined in the Company’s documents filed from time-to-time with the British Columbia Securities Commission on SEDAR at www.sedar.com.
Koios has not conducted any scientific studies on the effects of Koios’ products which have been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking Koios’ products will vary from person to person. No claims or guarantees can be made as to the effects of Koios’ products on an individual’s health and wellbeing.
For further information: Paula Arab, Media and Investor Relations Strategist, firstname.lastname@example.org, 403-889-9128